Related Experiment Videos
Prenatal exposure to sex hormones: a case-control study
M L Martínez-Frías1, E Rodríguez-Pinilla, E Bermejo
1ECEMC, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Teratology
|March 28, 1998
Summary
Prenatal sex hormone exposure does not increase the risk of birth defects. A large case-control study found no link between maternal hormone use during pregnancy and congenital malformations in offspring.
Area of Science:
- Reproductive endocrinology
- Teratology
- Pediatric medicine
Background:
- Therapeutic sex hormone use during pregnancy has raised concerns about potential adverse effects on offspring, specifically pseudohermaphroditism.
- Previous studies yielded conflicting results regarding the association between prenatal sex hormone exposure and congenital defects.
Purpose of the Study:
- To investigate the association between prenatal exposure to specific types of sex hormones and the risk of congenital malformations in offspring.
- To address the ongoing concerns about the safety of maternal hormone use during gestation.
Main Methods:
- A large-scale case-control study was conducted.
- Cases comprised malformed infants with unknown causes, excluding syndromes, known genetic disorders, and recognized teratogens.
- Controls were selected from the same population to ensure representativeness.
Main Results:
- Logistic regression analyses controlled for potential confounding factors.
- The study found no statistically significant increase in the risk of genital malformations associated with prenatal sex hormone exposure.
- No increased risk of nongenital malformations was observed in infants exposed to sex hormones during gestation.
Conclusions:
- The findings do not support the hypothesis that prenatal exposure to sex hormones elevates the risk of congenital malformations.
- This study provides evidence against a causal link between maternal sex hormone use and birth defects in offspring.